Preservation of T-Cell Subsets Following HAART

ID Number 00-0667-00021

Principal Investigator(s)
John B Steever

Department(s) or Division(s)


This is a study looking at a management strategy of induction with HAART (highly active antiretroviral therapy) including boosted Atazanavir (ATV/r) with subsequent de-intensification to ATV/r alone. The primary objective is to determine if the immunologic benefits of early initiation of treatment of HIV can be maintained or enhanced during de-intensification to ATV/r. In addition, the effect of implementing this management strategy on decreasing immune activation will be analyzed throughout the study and in particular during de-intensification.

Contact Information
John Steever
(212) 731-7517

Recruiting Patients: Yes